Amitiza - Sucampo Pharmaceuticals, Inc. - Treatment for ConstipationAmitiza is a selective chloride channel activator for the treatment of chronic idiopathic constipation in adults.
Posted: January 2006
- FDA Approves Amitiza for Opioid-Induced Constipation - April 23, 2013
- FDA Accepts Sucampo's sNDA for Lubiprostone (8 mcg) for the Treatment of Irritable Bowel Syndrome with Constipation (IBS-C) - September 17, 2007
- Sucampo Submits New Drug Application for Lubiprostone, an Investigational Compound for the Treatment of Chronic Idiopathic Constipation - April 1, 2005